Quantcast

Health Care Sector Update for 03/09/2018: PDLI,INSY,ARDM


Shutterstock photo

Top Health Care Stocks

JNJ +0.96%

PFE +0.51%

ABT +2.49%

MRK +0.59%

AMGN +1.29%

Health care stocks were ending on positive ground Friday, including a more than 1.0% gain for the NYSE Health Care Index in recent trade. Also today, shares of health care companies in the S&P 500 were up more than 1.3% as a group while the Nasdaq Biotechnology index was gaining almost 1.6% today.

Among health care stocks moving on news:

PDL BioPharma ( PDLI ) streaked to a more than 15% gain on Friday after the specialty drugmaker Thursday night reported Q4 net income of $0.15 per share, reversing a $0.06 per share net loss loss during the same quarter last year and easily topping the Capital IQ consensus expecting a $0.03 per share profit. Revenue during the three months ended Dec. 31 climbed to $68.0 million from $66.5 million last year, also eclipsing the $45.29 million analyst mean.

In other sector news:

Aradigm ( ARDM ) has hanging on a narrow gain Friday after the pharmaceuticals company said it has submitted a marketing authorization application with European regulators for its Linhaliq drug candidate to treat non-cystic fibrosis bronchiectasis in patients with a chronic lung infection and Pseudomonas aeruginosa. The move follows pre-submission meetings between Aradigm and the European Medicines Agency in October and November 2017, the company said. Linhaliq was found to be generally safe and well-tolerated during a pair of Phase III trials of the once-a-day inhaled formulation.

- Insys Therapeutics ( INSY ) plunged almost 13% at one point during Friday trading, sinking to a session low of $6.69 a share and the specialty drugmaker late Thursday reported an adjusted Q4 net loss missing Wall Street expectations and reversing a non-GAAP profit during the year-ago period. Excluding one-time items, the company fell to a net loss of $0.61 per share during the three months ended Dec. 31 compared with a $0.03 per share adjusted profit during the final three months in 2016 and lagging the Capital IQ consensus expecting a $0.14 per share net loss. Revenue fell to $31.49 million from $54.86 million last year, also trailing the $34.0 million Street view.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.



This article appears in: Investing , US Markets
Referenced Symbols: PDLI , ARDM , INSY



More from MT Newswires

Subscribe






MT Newswires
Contributor:

MT Newswires

Market News, Commodities










Research Brokers before you trade

Want to trade FX?